Literature DB >> 9122220

Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130.

A Kumanogoh1, S Marukawa, T Kumanogoh, H Hirota, K Yoshida, I S Lee, T Yasui, K Yoshida, T Taga, T Kishimoto.   

Abstract

gp130 is a common signal-transducing receptor component for the interleukin 6 family of cytokines functioning in, for example, immune, hematopoietic, and nervous systems. In this study, to investigate the physiological functions of gp130 and to determine the pathological consequences of impaired gp130 signals, we have generated transgenic mice expressing a cytoplasmically truncated form of mouse gp130. Expression of this form of gp130 in lymphocytes significantly suppressed interleukin 6-induced tyrosine phosphorylation of endogenous gp130 and a downstream signaling molecule, signal transducer and activator of transcription 3, indicating that this form has a dominant negative function. In spite of the impaired gp130 signals, the development of lymphocytes in the transgenic mice appeared normal in terms of surface marker phenotypes. These mice, however, exhibited severe defects in antigen-specific antibody production of most immunoglobulin isotypes other than IgM after immunization with 2,4-dinitrophenol-conjugated ovalbumin. These results demonstrate in vivo that gp130 is essential for antigen-specific antibody production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122220      PMCID: PMC20113          DOI: 10.1073/pnas.94.6.2478

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

Authors:  D P Gearing; M R Comeau; D J Friend; S D Gimpel; C J Thut; J McGourty; K K Brasher; J A King; S Gillis; B Mosley
Journal:  Science       Date:  1992-03-13       Impact factor: 47.728

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

Review 3.  Cytokine signal transduction.

Authors:  T Kishimoto; T Taga; S Akira
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

4.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

Review 5.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

6.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

Authors:  N Stahl; T G Boulton; T Farruggella; N Y Ip; S Davis; B A Witthuhn; F W Quelle; O Silvennoinen; G Barbieri; S Pellegrini
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

7.  STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.

Authors:  M Minami; M Inoue; S Wei; K Takeda; M Matsumoto; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

8.  Plaque Formation in Agar by Single Antibody-Producing Cells.

Authors:  N K Jerne; A A Nordin
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

9.  CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.

Authors:  E Castigli; F W Alt; L Davidson; A Bottaro; E Mizoguchi; A K Bhan; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma.

Authors:  H Hirota; H Kiyama; T Kishimoto; T Taga
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

View more
  13 in total

Review 1.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment.

Authors:  Wei Hu; Ty Dale Troutman; Ramakrishna Edukulla; Chandrashekhar Pasare
Journal:  Immunity       Date:  2011-12-01       Impact factor: 31.745

Review 3.  gp130 at the nexus of inflammation, autoimmunity, and cancer.

Authors:  J S Silver; C A Hunter
Journal:  J Leukoc Biol       Date:  2010-07-07       Impact factor: 4.962

4.  Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma.

Authors:  Anna K Scherger; Mona Al-Maarri; H. Carlo Maurer; Markus Schick; Sabine Maurer; Rupert Öllinger; Irene Gonzalez-Menendez; Manuela Martella; Markus Thaler; Konstanze Pechloff; Katja Steiger; Sandrine Sander; Jürgen Ruland; Roland Rad; Leticia Quintanilla-Martinez; Frank T Wunderlich; Stefan Rose-John; Ulrich Keller
Journal:  JCI Insight       Date:  2019-08-08

5.  Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells.

Authors:  Jamie L Fornek; Lorraine T Tygrett; Thomas J Waldschmidt; Valeria Poli; Robert C Rickert; Geoffrey S Kansas
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

6.  A role for IL-27p28 as an antagonist of gp130-mediated signaling.

Authors:  Jason S Stumhofer; Elia D Tait; William J Quinn; Nancy Hosken; Björn Spudy; Radhika Goenka; Ceri A Fielding; Aisling C O'Hara; Yi Chen; Michael L Jones; Christiaan J M Saris; Stefan Rose-John; Daniel J Cua; Simon A Jones; Merle M Elloso; Joachim Grötzinger; Michael P Cancro; Steven D Levin; Christopher A Hunter
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

7.  Silencing of B cell receptor signals in human naive B cells.

Authors:  Niklas Feldhahn; Ines Schwering; Sanggyu Lee; Maria Wartenberg; Florian Klein; Hui Wang; Guolin Zhou; San Ming Wang; Janet D Rowley; Jürgen Hescheler; Martin Krönke; Klaus Rajewsky; Ralf Küppers; Markus Müschen
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

8.  Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.

Authors:  M Ernst; M Inglese; P Waring; I K Campbell; S Bao; F J Clay; W S Alexander; I P Wicks; D M Tarlinton; U Novak; J K Heath; A R Dunn
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

9.  Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component.

Authors:  M Kopf; S Herren; M V Wiles; M B Pepys; M H Kosco-Vilbois
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

10.  The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells.

Authors:  Oliver Dienz; Sheri M Eaton; Jeffrey P Bond; Wendy Neveu; David Moquin; Rajkumar Noubade; Eva M Briso; Colette Charland; Warren J Leonard; Gennaro Ciliberto; Cory Teuscher; Laura Haynes; Mercedes Rincon
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.